跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
万立能 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Siponimod Tablets
Approved
化学药品
Siponimod Tablets
Novartis Pharma Schweiz AG
🇨🇳 National Medical Products Administration
Approval Date
May 7, 2020
Approval ID
7yn0clDurLv
Company
Novartis Pharma Schweiz AG
Type
化学药品
Approval Details
Approval Id
7yn0clDurLv
Approval Number
H20200010
Generic Name
西尼莫德片
Generic Name En
Siponimod Tablets
Trade Name
万立能
Brand Name
万立能
Drug Type
化学药品
Dosage Form
片剂
Strength
0.25mg(按C58H70F6N4O6计)
Reg Date
2020-05-07
Expired Date
2025-05-06
Company Name
Novartis Pharma Schweiz AG
Company Address
6343 Risch, Switzerland
Production Company Name
Novartis Pharma Stein AG
Production Company Address
Schaffhauserstrasse 4332 Stein,Switzerland
Company Detail Path
/organization/novartis-pharma-schweiz-ag
Production Company Detail Path
/organization/novartis-pharma-stein-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 7, 2020
Approval ID
7yn0clDurLv
Type
化学药品
Back to NMPA Approvals